|
As reported in a research article, a vegetation and endocarditis was found on a valve that had been implanted for five years.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
The abstract article, "trifecta bioprostheses: evaluation of the safety based on the study of degenerations according to the varc-3 classification", was reviewed.The research article is a retrospective single center experience to evaluate the intrinsic imputability of trifecta for dysfunction according to the varc-3 classification in patients implanted and to reassess their referencing in our center.Trifecta valve was the device associated with this study.The article concluded, the classification of failures according to varc-3 indicated the intrinsic imputability of the trifecta¿ bioprostheses regarding to the number of svd-type dysfunctions.Although this study has limitations, it shows the understatement of medical-devices-vigilance cases by the medical staff.[the primary author of this article is richez, ophelie, amiens-picardie university hospital, 1 rond-point du professeur christian cabrol, 80054 amiens, france, with email address of : richez.Ophelie@chu-amiens.Fr].It was reported that in (b)(6) 2013, a 25mm trifecta valve was implanted in a patient with a past medical history of aortic insufficiency.It was reported that in (b)(6) 2018, the patient had mitro-aortic endocarditis, eccentric receding bioprosthesis plunging towards the large mitral valve.The was also lower right sigmoid thickening which remains mobile, vegetation > 10mm.No abscess or paraprosthetic leak.7mm vibrate image on the auricular side of the small mitral valve with im grade 1.Absence of damage to the other valves.On (b)(6) 2018, a surgical intervention was completed with a new trifecta 25mm valve.Post procedure of the second valve in (b)(6) 2020, there was dilation of the ascending aorta measured at 4 cm greater, poly-valvular heart disease with a significant mitral leak and severe aortic insufficiency and ac / af.Requiring replacement with a 21mmregent heart valve w/flex cuff.Patient status is unknown, no additional information was provided.
|